CoraLite® Plus 555 Anti-Mouse CD103 (2E7)

CD103 Monoclonal Antibody for FC
Cat No. CL555-65047

产品说明书

CloneNo. 2E7

宿主/亚型

Hamster / IgG

种属反应性

Mouse

应用

FC

A530055J10, alpha E1, alpha M290, aM290, CD103, Itgae

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 

-/ -


经过测试的应用

Positive FC detected inmouse splenocytes
For other applications, we recommend the unconjugated version of this antibody, 65047-1-Ig

推荐稀释比

应用推荐稀释比
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL555-65047 targets CD103 in FC applications and shows reactivity with Mouse samples.

经测试应用 FC Application Description
经测试反应性 Mouse
免疫原 C57BL/6J mouse intestinal intraepithelial lymphocytes (IEL) 种属同源性预测
宿主/亚型 Hamster / IgG
抗体类别 Monoclonal
产品类型 Antibody
全称 integrin alpha E, epithelial-associated
别名 A530055J10, alpha E1, alpha M290, aM290, CD103, Itgae
GenBank蛋白编号BC150690
基因名称 CD103
Gene ID (NCBI) 16407
RRIDAB_3084536
偶联类型 CoraLite® Plus 555 Fluorescent Dye
最大激发/发射波长554 nm / 570 nm
形式 Liquid
纯化方式Affinity purification
UNIPROT IDQ60677
储存缓冲液 PBS with 0.09% sodium azide , pH 7.3
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

CD103, also known as integrin alpha-E (ITGAE) or integrin alpha-IEL, is a type I transmembrane integrin protein that binds integrin beta 7 to form Integrin alpha-E beta-7 which is a receptor for E-cadherin and mediates adhesion of T lymphocytes to epithelial cells (PMID: 7969453; 8468482). CD103 is expressed on intraepithelial lymphocyte (IEL) T cells (both alpha/beta T cells and gamma/delta T cells), some peripheral regulatory T cells (Tregs), lamina propria T cells, and a subset of dendritic cells in the gut mucosa and mesenteric lymph nodes (PMID: 12242333; 15608520; 16216890).

实验方案

Product Specific Protocols
FC protocol for CL Plus 555 CD103 antibody CL555-65047Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...